Daclizumab high-yield process in the treatment of relapsing–remitting multiple sclerosis

Por Preiningerova, Jana Lizrova, Vachova, Marta
Publicado no Ther Adv Neurol Disord (2016)

Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5)

Por Lizrova Preiningerova, Jana, Novotna, Klara, Rusz, Jan, Sucha, Lucie, Ruzicka, Evzen, Havrdova, Eva
Publicado no J Neuroeng Rehabil (2015)

Changes of Retina Are Not Involved in the Genesis of Visual Hallucinations in Parkinson's Disease

Por Kopal, Aleš, Mejzlíková, Eva, Preiningerová, Jana Lízrová, Brebera, David, Ulmanová, Olga, Ehler, Edvard, Roth, Jan
Publicado no Parkinsons Dis (2015)

Transplantation of Cryopreserved Adult Human Schwann Cells Enhances Axonal Conduction in Demyelinated Spinal Cord

Por Kohama, Ikuhide, Lankford, Karen L., Preiningerova, Jana, White, Fletcher A., Vollmer, Timothy L., Kocsis, Jeffery D.
Publicado em 2001

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study

Por Yadav, Vijayshree, Bourdette, Dennis N., Bowen, James D., Lynch, Sharon G., Mattson, David, Preiningerova, Jana, Bever, Christopher T., Simon, Jack, Goldstein, Andrew, Burrows, Gregory G., Offner, Halina, Ferro, Al J., Vandenbark, Arthur A.
Publicado em 2012